Evidence map›Paper›PMID 40943379›Full record

ArticleInternational journal of molecular sciences2025

Deriving the A/B Cells Policy as a Robust Multi-Object Cell Pipeline for Time-Lapse Microscopy.

Ilya Larin, Egor Panferov, Maria Dodina, Diana Shaykhutdinova, Sofia Larina, Ekaterina Minskaia, Alexander Karabelsky

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ilya LarinTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.ORCID 0000-0002-5005-0749
Egor PanferovTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.ORCID 0000-0002-9368-2287
Maria DodinaTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.
Diana ShaykhutdinovaTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.
Sofia LarinaIT-College, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.
Ekaterina MinskaiaTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.ORCID 0000-0002-1137-373X
Alexander KarabelskyTranslational Medicine Research Center, Sirius University of Science and Technology, Federal Territory Sirius, Olympic Ave. 1, 354340 Sirius, Russia.ORCID 0000-0002-6391-5182

Funding

The APC was funded by the grant of the state program of the "Sirius Federal Territory Scientific and technological development of the Sirius Federal Territory" Agreement No. 18-03 on 10 September 2024This research was funded by the grant of the state program of the "Sirius Federal Territory Scientific and technological development of the Sirius Federal Territory" Agreement No. 18-03 on 10 September 2024
6 · The paper itself

Abstract

Time-lapse microscopy of mesenchymal stem cell (MSC) cultures allows for the quantitative observation of their self-renewal, proliferation, and differentiation. However, the rigorous comparison of two conditions, baseline (A) versus perturbation (B) (the addition of molecular factors, environmental shifts, genetic modification, etc.), remains difficult because morphology, division timing, and migratory behavior are highly heterogeneous at the single-cell scale. MSCs can be used as an in vitro model to study cell morphology and kinetics in order to assess the effect of, for example, gene therapy and prime editing in the near future. By combining static, frame-wise morphology with dynamic descriptors, we can obtain weight profiles that highlight which morphological and behavioral dimensions drive divergence. In this study, we present A/B Cells Policy: a modular, open-source Python package implementing a robust cell tracking pipeline. It integrates a YOLO-based architecture as a two-stage assignment framework with fallback and recovery passes, re-identification of lost tracks, and lineage reconstruction. The framework links descriptive statistics to a transferable system, opening up avenues for regenerative medicine, pharmacology, and early translational pipelines. It does this by providing an interpretable, measurement-based bridge between in vitro imaging and in silico intervention strategy planning.

Indexed as

Cell TrackingMesenchymal Stem CellsMicroscopyTime-Lapse ImagingCell DifferentiationHumansSoftwareA/B modelscell trackingdescriptive statisticsMSC

Identifiers

PMID40943379
PMCPMC12429040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.